Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 5 of 16
Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Cancer
NCT05932810
Partial Heart Transplantation for Severe Pediatric Semilunar Valve Dysfunction
NCT05372757
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
NCT05796791
Extending taVNS Paired With Infant CIMT Into a Home-Based Setting
NCT05857527
Stepped Care for Aphasia
NCT05851573
Mepivacaine Vs. Bupivacaine Spinal for TKA
NCT05765682
QL vs PENG for Analgesia After Hip Arthroplasty
NCT05710107
Wearable Technology and Alcohol-Facilitated Intimate Partner Violence
NCT05374798
SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers
NCT05501119
taVNS on the Inpatient Psychiatric Unit
NCT05791383
Cannabidiol in Youth Alcohol Use Disorder
NCT05317546
Coaching Children With Anxiety and Autism Through Telehealth
NCT05588570
Learning in Stroke
NCT05511467
iPACK for Post-op Pain Following ACL Reconstruction
NCT05498870
ITM vs QL for Pediatric Open Lower Abdominal Procedures
NCT05506930
Quit or Switch: E-cigarette Study
NCT05525078
Reshaping the Motor Engram - An Online Crowdsourcing Study.
NCT05511480
BabyStrong Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Paired Bottle Feeding to Improve Oral Feeding
NCT04849507
Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.
NCT05182151
CPT-L to Improve Outcomes for Individuals With HIV and PTSD
NCT05275842
Post-stroke Fatigue, Inflammation, tDCS
NCT05330988
Learning and Ear Stimulation
NCT04812015
Telemedicine Optimized Burn Intervention
NCT05019144
Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder
NCT05340504
Musical Engagement of Brain LObes in Alzheimer's Disease Patients StudY
NCT05309369
BioWare for AUD and PTSD
NCT05187364
Time Restricted Eating on Cancer Risk
NCT05038137
Neoadjuvant Imiquimod Immunotherapy for Oral Cancer
NCT04883645
CIMT and taVNS for Hemiplegia in Infants
NCT05101707
DDN in Stroke--COBRE
NCT05196737
Tarlox and Sotorasib in Patients With KRAS G12C Mutations
NCT05313009
Using mHealth to Improve Emotional Recovery After Pediatric Injury
NCT04579198
SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
NCT05230693
Telehealth Rapid Intervention for Externalizing Behaviors in ASD
NCT05056922
rTMS for Stimulant Use Disorders
NCT04907357
Tourniquets Increase Proximal Pressure
NCT05324306
KAP for Depression in Abstinent Opioid Users
NCT05193318
Managing AsThma AnD Obesity Related Symptoms (MATADORS) Feasibility Study
NCT05742646
Peer Intervention to Link Overdose Survivors to Treatment (PILOT)
NCT05123027
Registry of Emergent Large VeSsel OCclUsion DuE to IntraCranial AtherosclerosiS
NCT05403593
The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia
NCT04594733
Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca
NCT05070754
Stress-Reactivity and Cannabis Use in Cannabis-Using Older Adults
NCT05072795
Breathwork App for Cancer Survivors
NCT05161260
Gender/Sex & CUD Remission
NCT04964739
Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment
NCT04738149
Evaluation of a Mobile Therapy for Elevated Depressive Symptoms
NCT04463914
Post-stroke Perturbation Training
NCT04855032
taVNS Cold Pressor
NCT05254080
Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes
NCT04831684
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.